Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan

• Main Authors: Takano K, Watanabe Y, Hariu M, Seki M
• Format: Article
• Language: English
• Published: Dove Medical Press 2021-07-01
• Series: Infection and Drug Resistance
• Subjects: covid-19; n501y; e484k; p681h; pcr; remdesivir; vaccine
• Online Access: https://www.dovepress.com/detection-of-representative-mutant-strains-and-a-case-of-prolonged-inf-peer-reviewed-fulltext-article-IDR

Kazuki Takano,1,2 Yuji Watanabe,1,2 Maya Hariu,1,2 Masafumi Seki1 1Division of Infectious Diseases and Infection Control; 2Laboratory for Clinical Microbiology, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi, JapanCorrespondence: Masafumi SekiDivision of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1 Fukumuro, Miyagino-ku, Sendai City, Miyagi, 983-8612, JapanTel [phone]Fax [phone]Email [e-mail]: There is a concern that the spread of mutant strains of SARS-CoV-2 will increase the number of severe COVID-19 patients and weaken vaccine effectiveness in the world. The mutants of the spike region of SARS-CoV-2, such as N501Y, E484K, P681H, and deletion H69/V70 (del 69/70), were studied in 25 COVID-19 patients admitted from December 2020 to April 2021; there were no patients with N501Y and P681H, but nine patients had E484K alone. Their symptoms, laboratory data, and course of their disease were similar to those of the other patients with the non-mutant virus. One patient with del69/70 alone showed prolonged inflammation, viral excretion, and late exacerbation 18 days after onset. Del69/70 may be independently associated with evasion of immunity, as previously reported, and it is present in Japan.Keywords: COVID-19, N501Y, E484K, P681H, PCR, remdesivir, vaccine